The Emerging Risk Factors Collaboration, Di Angelantonio E …[143 authors] …Thompson SG, Walker M, Watson S, Wood AM, Wormser D, Zhao X, Danesh J. Lipid-related markers and cardiovascular disease prediction. JAMA 2012;307:2499-506.
The Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM …[273 authors] …Thompson SG, Danesh J. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012;367:1310-20.
IL6R Genetics Consortium and The Emerging Risk Factors Collaboration, Sarwar N, Butterworth AS, Freitag DF …[221 authors] … Samani NJ, Kaptoge S, Di Angelantonio E, Harari O, Danesh J. Interleukin-6 receptor pathways in coronary disease: a collaborative meta-analysis of 82 studies. Lancet 2012;379:1205-13.
Lorenz MW…[17 authors] …Thompson SG. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual particpant data. Lancet 2012;379:2053-62.
The Emerging Risk Factors Collaboration: (writing committee: Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, Butterworth AS, Sarwar N, Wormser D, Saleheen D, Ballantyne CM, Psaty BM, Sundström J, Ridker PM, Nagel D, Gillum RF, Ford I, Ducimetiere P, Kiechl S, Koenig W, Dullaart RPF, Assmann G, D’Agostino RB, Dagenais GR, Cooper JA, Kromhout D, Onat A, Tipping RW, Gómez-de-la-Cámara A, Rosengren A, Sutherland SE, Gallacher J, Fowkes FGR, Casiglia E, Hofman A, Salomaa V, Barrett-Connor E, Clarke R, Brunner E, Jukema JW, Simons LA, Sandhu M, Wareham NJ, Khaw KT, Kauhanen J, Salonen JT, Howard WJ, Nordestgaard BG Wood AM, Thompson SG, Boekholdt SM, Sattar N, Packard C, Gudnason V, Danesh J). Lipid-related markers and cardiovascualar disease prediction. JAMA 2012;307:2499-506.
The Emerging Risk Factors Collaboration: (writing committee: Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJL, Barr ELM, Barrett-Connor E, Benjamin MEJ, Björkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D’Agostino RB, Dankner R, Davey-Smith G, Deeg D, Dekker JM, Engström G, Folsom AR, Fowkes FGR, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jørgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CDA, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GDO, Sattar N, Wareham NJ, Khaw K-T, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J). C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012;367:1310-20.
van der Harst P, Zhang W, Mateo Leach, et al. Seventy-five genetic loci influencing the human red blood cell. Nature 2012;492:369-75.
The Emerging Risk Factors Collaboration: (writing committee: Wormser D, Di Angelantonio E, Kaptoge S, Wood A, Gao P, Sun Q, Wallidus G, Selmer R, Verschuren WMM, Bueno-de-Mesquita HB, Engström G, Ridker PM, Njølstrad I, Hiroyasu I,Holme I, Giampaoli S, Tunstall-Pedoe H, Gaziano JM, Brunner E, Kee F, Tosetto A, Meisinger C, Brenner H, Ducimetiere P, Whincup PH, Tippping RW, Ford I, Cremer P, Hofman A, Wihelmsen L, Clarke R, de Boer IH, Jukema JW, Ibanẽz AM, Lawlor DA, D’Agostino RB, Rodriguez B, Casiglia E, Stehouwer CDA, Simons LA, Nietert PJ, Barrett-Connor E, Panagiotakos DB, Björkelund C, Strandberg TE, Wassertheil-Smoller S, Blazer DG, Meade TW, Welin L, Svärdsudd K, Woodward M, Nissinen A, Kromhout D, Jørgensen T, Tilvis RS, Guralnik JM, Rosengren A, Taylor JO, Kiechl S, Dagenais GR, Fowkes FGR, Wallace RB, Khaw K-T, Shaffer JA, Visser M, Kauhanen J, Salonen JT, Gallacher J, Ben-Shlomo Y, Kitamura A, Sundström J, Kiyohara Y, Daimon M, Gómez de la Cámara A, Cooper JA, Onat A, Devereux R, Mukamal KJ, Dankner R, Knuiman MW, Crespo CJ, Gansevoort RT, Goldbourt U, Nordestgaard BG, Shaw JE, Mussolino M, Nakagawa H, Fletcher A, Kuller LH, Gillum RF, Gudnason V, Assmann G, Wald N, Jousilahti PR, Greenland P, Trevisan M, Ulmer H, Butterworth AS, Folsom AR, Davey-Smith G, Hu FB, Danesh J). Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol 2012;41:1419-33.
Voight BF, Peloso GM, Orho-Melander M,et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012;380:572-80.
IL6R Genetics Consortium and The Emerging Risk Factors Collaboration: (writing committee: Sarwar N, Butterworth AS, Freitag DF, et al). Interleukin-6 receptor pathways in coronary disease: a collaborative meta-analysis of 82 studies. Lancet 2012;379:1205-13.
Burgess S, Butterworth A, Malarstig A, Thompson SG. Use of Mendelian randomisation to assess potential benefit of clinical intervention. BMJ 2012;345:e7325.
Lorenz MW, Polak JF, Kavousi M, Mathiesen EB, Völzke H, Tuomainen TP, Sander D, Plichart M, Catapano AL, Robertson CM, Kiechl S, Rundek T, Desvarieux M, Lind L, Schmid C, DasMahapatra P, Gao L, Ziegelbauer K, Bots ML, Thompson SG; PROG-IMT Study Group. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual particpant data. Lancet 2012;379:2053-62.